Gemcitabine in the treatment of cholangiocarcinoma. Report of four cases;Gemcitabina en 4 pacientes con colangiocarcinoma

Revista Medica de Chile

Volumn 129, Issue 8, 2001, Pages 911-916

  Gallardo E, Jorge ^b   Cabrera A, Elsa ^b   Rubio L, Betzabé ^b   González V, Carolina ^a   Cortés A, Claudio ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b NONE

Author keywords

Cholangiocarcinoma; Cholangiography; Gemcitabine

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

AGED; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CASE REPORT; FEMALE; HUMAN; MALE; MIDDLE AGED; REVIEW; SURVIVAL; TREATMENT OUTCOME;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; DEOXYCYTIDINE; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035431801     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. LANDIS SH, MURRAY T, BOLDEN S, WINGO PA. Cancer statistics, 1998. CA Cancer J Clin 1998; 48: 6-29.
2. NAKEEB A, PITT HA, SOHN TA, COLEMAN J, ABRAMS RA, PIANTADOSI S ET AL. Cholangiocarcinoma. A spectrum of intrahepatic, perihiliar and distal tumors. Ann Surg 1996; 224: 463-75.
3. FARLEY DR, WEAVER AL, NAGORNEY DM. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 1995; 70: 425-9.
4. KLEMPNAUER J, RIDDER GJ, WERNER M, WEIMANN A, PICHLMAYR R. What constitutes long term survival after surgery for hiliar cholangiocarcinoma? Cancer 1997; 79: 26-34.
5. a edición, Lippincott-Raven Publishers, 1997; págs 1114-28.
6. WASHBURN WK, LEWIS WD, JENKINS RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg 1995; 130: 270-6.
7. PITT HA, NAKEEB A, ABRAMS RA, COLEMAN J, PIANTADOSI S, YEO CJ ET AL. Perihiliar cholangiocarcinoma: postoperative radiotherapy does not improve survival. Ann Surg 1995; 221: 788-98.
8. CURLEY SA, LEVIN B, RICH TA. Liver and Bile Ducts Cancer. En Abeloff MD, Armitage J. Clinical Oncology Churchill Livingstone Inc 1995; págs 1305-72.
9. JONES DV, LOZANO R, HOQUE A, MARKOWITZ A, PATT YZ. Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas. J Clin Oncol 1996; 14: 2306-10.
10. KAJANTI M, PYRHONEN S. Epirubicin sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system: A phase II study. Am J Clin Oncol 1994; 17: 223-6.
11. ECKEL F, LERSCH C, ASSMANN G, SCHULTE-FROHLINDE E. Phase II trial of low dose cyclophosphamide, leucovorin, high dose 5-fluorouracil 24 hours continuous infusion and tamoxifen in advanced biliary tract cancer. Ann Oncol 2000; 11: 762-3.
12. DE GROEN PC, GORES GJ, LARUSSO NF, GUNDERSON LL, NAGORNEY DM. Biliary Tract Cancers. N Engl J Med 1999; 341: 1368-78.
13. OBERFIELD RA, ROSSI RL. The role of chemotherapy in the treatment of bile duct cancer. World J Surg 1988; 12: 105-8.
14. FALKSON G, MACINTYRE JM, MOERTEL CG. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 1984; 54: 965-9.
15. TAKADA T, KATO H, MATSUSHIRO T, NIMURA Y, NAGAKAWA T, NAKAYAMA T. Comparison of 5-fluorouracil, doxorubicin and mitomycin-C with 5-fluorouracil alone in the treatment of pancreaticbiliary carcinomas. Oncology 1994; 51: 396-400.
16. PATT YZ, JONES DVJ, HOQUE A, LOZANO R, MARKOWITZ A, RAIJMAN I ET AL. Phase II trial of intravenous fluorouracil and subcutaneous interferon -α-2b for biliary tract cancer. J Clin Oncol 1996; 14: 2311-5.
17. ELLIS PA, NORMAN A, HILL A, O'BRIEN ME, NICOLSON M, HICKISH T, CUNNINGHAM D. Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer 1995; 31: 1594-8.
18. DUCREUX M, ROUGIER P, FANDI A, CLAVERO MC, VILLING L, FASSONE F ET AL. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 1998; 9: 653-6.
19. SANZ-ALTAMIRA PM, FERRANTE K, JENKINS RL, LEWIS WD, HUBERMAN MS, STUART KE. A phase II trial of 5-fluorouracil, leucovorin and carboplatin in patients with unresectable biliary tree carcinoma. Cancer 1998; 82: 2321-5.